These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 10911466

  • 21. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [Abstract] [Full Text] [Related]

  • 22. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.
    Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N.
    J Rheumatol; 1996 May; 23(5):919-24. PubMed ID: 8724309
    [Abstract] [Full Text] [Related]

  • 23. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [Abstract] [Full Text] [Related]

  • 24. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis.
    Wallace CA, Sherry DD.
    J Rheumatol; 1992 Oct; 19(10):1604-7. PubMed ID: 1464876
    [Abstract] [Full Text] [Related]

  • 25. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [Abstract] [Full Text] [Related]

  • 26. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort.
    Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M.
    J Rheumatol; 2002 Sep; 29(9):1989-99. PubMed ID: 12233897
    [Abstract] [Full Text] [Related]

  • 27. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register.
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [Abstract] [Full Text] [Related]

  • 28. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J.
    Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
    [Abstract] [Full Text] [Related]

  • 29. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 30. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439
    [Abstract] [Full Text] [Related]

  • 31. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS.
    N Engl J Med; 1992 Apr 16; 326(16):1043-9. PubMed ID: 1549149
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
    Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A.
    J Rheumatol; 2001 Jul 16; 28(7):1677-80. PubMed ID: 11469478
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
    Arthritis Rheum; 2002 Aug 16; 46(8):2020-8. PubMed ID: 12209503
    [Abstract] [Full Text] [Related]

  • 34. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
    Ravelli A, Di Fuccia G, Molinaro M, Ramenghi B, Zonta L, Regazzi MB, Martini A.
    J Rheumatol; 1993 Sep 16; 20(9):1573-7. PubMed ID: 8164218
    [Abstract] [Full Text] [Related]

  • 35. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J.
    J Clin Rheumatol; 2009 Jun 16; 15(4):161-4. PubMed ID: 19363453
    [Abstract] [Full Text] [Related]

  • 36. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I.
    Arthritis Rheum; 2000 Aug 16; 43(8):1849-57. PubMed ID: 10943876
    [Abstract] [Full Text] [Related]

  • 37. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D.
    Arthritis Rheum; 2002 Mar 16; 46(3):614-24. PubMed ID: 11920396
    [Abstract] [Full Text] [Related]

  • 38. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L.
    J Rheumatol; 2000 Aug 16; 27(8):2018-24. PubMed ID: 10955346
    [Abstract] [Full Text] [Related]

  • 39. Leflunomide or methotrexate for juvenile rheumatoid arthritis.
    Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewart JA, Strand V, Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group.
    N Engl J Med; 2005 Apr 21; 352(16):1655-66. PubMed ID: 15843668
    [Abstract] [Full Text] [Related]

  • 40. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML, van Haandel L, Gaedigk R, Lasky A, Hoeltzel M, Stobaugh J, Leeder JS.
    Arthritis Rheum; 2010 Jun 21; 62(6):1803-12. PubMed ID: 20191581
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.